No ‘shot-cut’ out of the pandemic
Rich nations’ vaccine nationalism—the third (booster) dose proposals are one example—complicates the response to the pandemic
Will ‘Merkel mix’ set a trend of Covid-19 vaccine cocktails?
Need to probe safety and efficacy of mixing Covid shots that use different platforms, in the light of possible immunity blow to efficacy of the second dose of the same vax
Covid-19 vaccine: Time to test Covishield-Covaxin mix for immune response against D variant
Perhaps it is time for our scientists to test whether a mix of Covishield and Covaxin will increase the chances of a more effective immune response against the D variant
Reading Vaccine Findings Right: Covid vaccines get a reality check
Both the UK and the double-mutant variants seem to be subdued by the AstraZeneca and Pfizer vaccines, but the hardier double-mutant is less responsive
Combination numbers to open Covid lockdown
The growth rate of weekly average of the number of positive cases, Covid diagnosed/suspected deaths and hospital admissions need to inform unlock decisions
Patents must not impede pandemic response
Patents restrict access to essential technologies and constrict the ability of many countries to provide early and affordable services needed for an effective and equitable response
Covid-19: Fight the war, don’t battle waves
We must not let ourselves get trapped in a see-saw of lockdowns and laxity. Need to ensure testing, tracing and masking/distancing
Vaccine efficacy claims have confidence limits
It is necessary to report the 95% confidence intervals around both the overall vaccine trial result and for the values being reported for any subgroup of interest
Budget 2021: A broader head for healthcare
Union Budget 2021 India: Laboratory capacity will be expanded and One Health surveillance connectivity will be established across wildlife, veterinary and human populations.
Budget 2021 expectations: Budget must provide a booster shot for health
Union Budget 2021 Expectations for health sector: Increased spending on primary care will reflect the twin priorities of an effective pandemic response and building a stronger health system for the long term
Covid-19: Will the promise of vaccines match the promos?
‘Science by press release’ may be good for value of developers’ stocks, but regulatory approvals & public-health use require rigorously gathered, honestly reported data
When must politicians listen to scientists?
The purpose of scientific research in public health is to provide evidence-informed, context-relevant, resource optimising, culturally compatible and equity promoting recommendations
Depending on big hospitals to provide most of Post-Covid care is setting ourselves up for failure
Depending on big hospitals to provide most of Post-COvid care is setting ourselves up for failure. Community-based facilities, in or near PHcs, would be more accessible
Covid-19 outbreak and the RAT rage
The Year of the Rat is now seeing a rise in rapid antigen testing (RAT) for Covid-19.
Covid-19 bowls a re-infection googly
We have to maintain vigilance against the first bout of Covid-19 infection and draw assurance from the fact that our immune system cAn deal with reinfections
Covid vaccine race: Unfazed claims on ‘un-phased’ trials?
Commercial interests too play a very strong role since there is much money to be made for the industry, though the foundational science is public-funded.
Covid-19: Making sense of the sero-survey
The true prevalence rates are most likely to be lower than the rates reported, because of the inflation of false positives on mass screening.
Why using Covid-19 antigen test sensibly is important
With a multiplicity of tests, a problem will arise with the reporting and interpretation of total testing numbers.
Comparing countries on Covid-19 deaths
We need a slew of public health measures to contain Covid-19 and keep the total deaths in our population low even as the count of cases rises
Coronavirus pandemic: Covid, critics and contradictions
India should move ahead with the undeterred resolve of adopting context-defined and regionally-differentiated strategies, undistracted by critics
Clues to crack the COVID-19 puzzle
However, these measures tell us how well a test behaves in a group of persons, not particularly about the individual being tested.
Reading the Covid-19 numbers right
Talking about doubling-time between given periods without taking into account whether the underlying testing/case identification factors are comparable or not, or comparing case fatality ratios of countries without age-standa
Budget 2020: Health moves to private fast track
Budget 2020-21: Just as Anganwadi workers will be equipped with smartphones, frontline health workers too must be technology enabled to make primary healthcare more accessible, efficient and less doctor dependant
Guiding nutrition through thick and thin
Those who studied ‘undernutrition’ saw underweight, wasted or stunted children, or thin and anaemic adults as deficient in calories and essential nutrients.
Sound law: Defining a right to health
Madhya Pradesh will focus on access to clean water, nutrition, & other factors impacting health, apart from access to healthcare. Other states should emulate it
Ailing healthcare system needs more healing hands
The fault lines of the Indian healthcare system, especially those of our understaffed and under-skilled health workforce, are in urgent need of repair
Falling maternal mortality: Mothered by primary care & public financing
Two messages come through from the Indian experience: First, strong primary health care is essential to achieve the maximum impact. Second, public financing is vital for infrastructure development, health workforce skilling,
Advertisement
US Stock Market
View All- Wall Street tech stocks running out of steam; value stocks could take centre stage now
- US Stocks get ‘monster’ inflows as traders exit cash on Fed relief
- U.S. stocks gain the most since August as Nasdaq 100 rose for the first time in more than a week
- More S&P 500 companies discussing ESG and how well ESG investing has performed – Find out
- Chennai startup to soon list on NASDAQ, plans raising $912 million through public issue
Most Read
- Wall Street Week Ahead: Growth? Value? Some investors opt for a bit of both
- Dish TV seeks to extend AGM, says requires regulatory nod for suggested changes on board
- Corona LIVE: Lockdown norms relaxed in UP, upto 100 people allowed to gather at places outside containment zones; Kerala logs 19,653 cases
- The Algerian Connect – India upgrades its relationship with the African nation
- Charanjit Singh Channi to succeed Amarinder Singh as Punjab Chief Minister
- Politics of opportunism in Kashmir must stop
- PayPal completes first international rollout of its crypto offering for users to buy, hold, sell coins
- M-cap of four of top-10 most-valued cos jumps Rs 65,464 cr; Airtel, SBI lead gainers
- Moratorium on telecom dues allows time to transform, repair; tariff wars unlikely: Deloitte India
- MSME loan share in commercial loans by value jumps over 50% in five years: Report
Advertisement
Top News
- Wall Street Week Ahead: Growth? Value? Some investors opt for a bit of both
- Dish TV seeks to extend AGM, says requires regulatory nod for suggested changes on board
- Corona LIVE: Lockdown norms relaxed in UP, upto 100 people allowed to gather at places outside containment zones; Kerala logs 19,653 cases
- The Algerian Connect – India upgrades its relationship with the African nation
- Charanjit Singh Channi to succeed Amarinder Singh as Punjab Chief Minister
- Politics of opportunism in Kashmir must stop
- PayPal completes first international rollout of its crypto offering for users to buy, hold, sell coins
- M-cap of four of top-10 most-valued cos jumps Rs 65,464 cr; Airtel, SBI lead gainers
- Moratorium on telecom dues allows time to transform, repair; tariff wars unlikely: Deloitte India
- MSME loan share in commercial loans by value jumps over 50% in five years: Report
Advertisement
